Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
THC
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
zacks.com
9 hours ago
zacks.com
10 hours ago
seekingalpha.com
12 hours ago
zacks.com
13 hours ago
zacks.com
19 hours ago
Earnings Growth
YoY
Current
Estimates
Q3.23
N/A
1.44
vs 1.44
Q4.23
+37%
2.68
vs 1.96
Q1.24
+127%
3.22
vs 1.42
Q2.24
+60%
2.31
vs 1.44
Q3.24
+103%
2.93
vs 1.44
Q4.24
+28%
3.44
vs 2.68
Q1.25
+35%
4.36
vs 3.22
Q2.25
+74%
4.02
vs 2.31
Q3.25
+14%
3.34
vs 2.93
Q4.25
+20%
4.12
vs 3.44
Sales Growth
YoY
Current
Estimates
Q3.23
+6%
5.1B vs 4.8B
Q4.23
+8%
5.4B vs 5B
Q1.24
+7%
5.4B vs 5B
Q2.24
+0%
5.1B vs 5.1B
Q3.24
+1%
5.1B vs 5.1B
Q4.24
-6%
5.1B vs 5.4B
Q1.25
-3%
5.2B vs 5.4B
Q2.25
+3%
5.3B vs 5.1B
Q3.25
+3%
5.3B vs 5.1B
Q4.25
+6%
5.4B vs 5.1B
Return on Equity
QoQ
Q1.23
+24%
0.24
vs 0.24
Q2.23
+9%
0.09
vs 0.24
Q3.23
+7%
0.07
vs 0.09
Q4.23
+15%
0.15
vs 0.07
Q1.24
+62%
0.62
vs 0.15
Q2.24
+7%
0.07
vs 0.62
Q3.24
+12%
0.12
vs 0.07
Q4.24
+8%
0.08
vs 0.12
Q1.25
+10%
0.1
vs 0.08
Q2.25
+8%
0.08
vs 0.1
Institutionnal Ownership
QoQ
Q1.23
393
393
vs 397
-1%
Q2.23
451
451
vs 393
15%
Q3.23
445
445
vs 451
-1%
Q4.23
469
469
vs 445
5%
Q1.24
499
499
vs 469
6%
Q2.24
571
571
vs 499
14%
Q3.24
642
642
vs 571
12%
Q4.24
631
631
vs 642
-2%
Q1.25
599
599
vs 631
-5%
Q2.25
651
651
vs 599
9%
Relative Strength
THC
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
205.00(6.32%)
Number of analyst
1
Last analyst upgrade/downgrade
Wolfe Research
downgradePrevious: Outperform
2025-07-28
Now: Peer Perform
Wells Fargo
upgradePrevious: Buy
2025-05-29
Now: Overweight
Morgan Stanley
initialisePrevious: Not converted
2025-03-26
Now: Overweight
Goldman Sachs
downgradePrevious: Buy
2024-12-16
Now: Neutral
Quote Panel
Key Metrics